Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets

Anton Bespalov,Thomas Steckler,Bruce Altevogt,Elena Koustova,Phil Skolnick,Daniel Deaver,Mark J. Millan,Jesper F. Bastlund,Dario Doller,Jeffrey Witkin,Paul Moser,Patricio O'Donnell,Ulrich Ebert,Mark A. Geyer,Eric Prinssen,Theresa Ballard,Malcolm Macleod

Nature Reviews Drug Discovery（2016）

Cited 54|Views17

Key words

Drug discovery and development,Neurological disorders,Biomedicine,general,Pharmacology/Toxicology,Biotechnology,Medicinal Chemistry,Molecular Medicine,Cancer Research

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined